USF Health’s IDPodcasts IDPodcasts

Dr. Lauren Rybolt, Infectious Diseases Fellow at the Division of Infectious Diseases, Morsani College of Medicine, discusses the ways that climate change is expected to alter the infectious diseases landscape. Dr. Rybolt begins her talk with the discussion of vector-borne diseases, and then goes on to discuss zoonotic infections, water-borne diseases, habitat changes, and natural disaster impacts. Lastly, Dr. Rybolt completes her talk by sharing information on climate change solutions and adaptations.

Dr. Guy Handley, Assistant Professor of Medicine with the Division of Infectious Diseases, USF Morsani College of Medicine, provides an overview of Human Herpesvirus 6 in Stem Cell Transplant Patients. Dr. Handley uses clinical cases to describe several scenarios related to HHV6 infection. Topics discussed include background, HHV6 latency, reactivation, clinical presentation, encephalitis, treatment strategies, and outcomes. Guidelines for HHV care are also discussed. Dr. Handley closes by discussing controversies and future directions in HHV6 management.

In a lively case-based format, Dr. Jackie Sherbuk, Assistant Professor of Medicine at the Division of Infectious Diseases, Moroni College of Medicine at USF, reviews important opportunistic infections (OI’s) in HIV/AIDS patients. Included in the talk, Dr. Sherbuk discusses effective timing of antiretrovirals in the setting of an opportunistic infection. She addresses HIV associated pulmonary disease, cerebral Toxoplasmosis, Cryptococcosis, esophageal candidiasis, cryptosporidiosis, Mycobacterium Avian Complex, and Histoplasmosis. Immune Reconstitution Inflammatory Syndrome (IRIS) is also discussed as a phenomenon when antiretroviral therapy is started in the setting of an OI.

Dr. Jamie Morano, Professor of Medicine at the Division of Infectious Diseases, USF Morsani College of Medicine, reviews the epidemiology of Tuberculosis and its relationship to Human Immunodeficiency Virus infection. Topics discussed include TB trends in the US, factors contributing to an increase in TB morbidity, tuberculosis transmission, TB screening, and progression to active disease. Next, Dr. Morano outlines the relationship between tuberculosis and HIV infection. She also presents pearls on the use of antiretrovirals in active TB treatment and how to utilize TB meds in patients who are on antiretrovirals.

Dr Guy Handley, Assistant Professor of Medicine at the Division of Infectious Diseases, Morsani College of Medicine, discusses the Clinical manifestations of Pneumocystis Jirovecii infections in a question and answer format. Dr. Handley begins the talk by giving an overview of Pneumocystis, including its history and taxonomy. He then discusses the typical presentation when it causes pneumonia (PCP), the most likely clinical manifestation. Dr. Handley then covers PCP treatment, including the most commonly used therapy (trimethoprim-sulfamethoxasole) and other alternatives. Next, diagnostic testing is discussed, including the use of the 1,3 Beta-Gucan test. Lastly, the use of Echinocandins for the treatment of PCP pneumonia is covered.

Dr. Jackie Sherbuk, Assistant Professor of Medicine at the Morsani College of Medicine Division of Infectious Diseases, presents this case-based review of the use of antiretroviral therapy in HIV/AIDS patients. Dr. Sherbuk begins by reviewing and available antireturovial options, including those that are considered first line. She also covers the use of antiretrovirals in special groups, including expectant mothers, elite controllers, treatment experienced patients, HBV/HIV connected patients, and patients with chronic renal insufficiency. Lastly, Dr. Sherbuk discusses the nuances of using co-formulated combinations of antiretrovirals and mentions the newer long-acting injectable preparations.